Compare JNJ & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JNJ | BLK |
|---|---|---|
| Founded | 1886 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 164.2B |
| IPO Year | 2003 | 2024 |
| Metric | JNJ | BLK |
|---|---|---|
| Price | $239.06 | $1,013.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 14 |
| Target Price | $238.20 | ★ $1,275.21 |
| AVG Volume (30 Days) | ★ 7.4M | 663.0K |
| Earning Date | 04-14-2026 | 04-14-2026 |
| Dividend Yield | ★ 2.36% | 2.21% |
| EPS Growth | ★ 90.50 | N/A |
| EPS | 2.14 | ★ 14.06 |
| Revenue | N/A | ★ $12,794,000,000.00 |
| Revenue This Year | $6.63 | $16.98 |
| Revenue Next Year | $7.43 | $10.72 |
| P/E Ratio | $108.08 | ★ $74.80 |
| Revenue Growth | N/A | ★ 16.18 |
| 52 Week Low | $150.73 | $917.39 |
| 52 Week High | $251.71 | $1,219.94 |
| Indicator | JNJ | BLK |
|---|---|---|
| Relative Strength Index (RSI) | 59.01 | 43.41 |
| Support Level | $233.83 | $987.16 |
| Resistance Level | $244.80 | $1,096.93 |
| Average True Range (ATR) | 4.60 | 24.00 |
| MACD | 0.22 | 2.13 |
| Stochastic Oscillator | 87.09 | 33.78 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
BlackRock is the largest asset manager in the world, with $14.041 trillion in assets under management at the end of December 2025. Its product mix is diverse, with 55% of managed assets in equity strategies, 23% in fixed income, 9% in multi-asset classes, 6% in money market funds, and 5% in alternatives. Passive strategies account for more than two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.